Slimming-injections

Explore the science behind slimming injections, how they work, and what to expect. Learn about the different types and their effectiveness in achieving your weight loss goals.

Exploring the availability of slimming injections on the NHS, eligibility criteria, and alternative weight loss solutions.

GLP-1 receptor agonist injections (semaglutide, liraglutide) are the primary injectable weight loss medications available in the UK. This article examines their mechanism, the clinical trial evidence for efficacy, documented side effects, and the difference between NHS-prescribed and private clinic access.

Two categories of 'slimming injections' have clinical evidence: GLP-1 receptor agonists (semaglutide/Wegovy, tirzepatide/Mounjaro) for systemic weight loss, and deoxycholic acid (Belkyra/Kybella) for localised submental fat reduction. Their evidence bases, mechanisms, and regulatory status in the UK are reviewed here.

Thinking about slimming injections? This guide breaks down the costs, factors influencing price, and explores effective alternatives for weight management.